Organization
AstraZeneca Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
AstraZeneca Plc
... up $1.37 billion for Johnson & Johnson, the company said. RELATED: Can AstraZeneca's Calquence really siphon share from AbbVie and J&J's Imbruvica? And more competition ...
... AstraZeneca and Merck (NYSE:MRK),known as MSD outside the United States and Canada, today ...
... Inc. - Alkermes Plc - Allergan, Plc - Amneal Pharmaceuticals, LLC - AstraZeneca Plc - BIAL Group Download the full report: CNS THERAPEUTICS MCP-1835 A ...
... Global Heart Failure Drugs Market 2018-2022 - Amgen, AstraZeneca, Bayer, and Novartis are Dominating the Market - ResearchAndMarkets.com ...
... on how to navigate this complex journey. That's why I'm partnering with AstraZeneca on Survivors Have Heart to help to educate patients who have had ...
... of their existing global drug discovery collaboration with the global biopharmaceutical company AstraZeneca. The new agreement focuses on the synthesis and delivery of custom libraries ...
... M&A and licensing. They include some of the industry's most recognizable names (AstraZeneca, Celgene, and Merck) and life sciences upstarts like Rigontec, CureVac, and IFM ...
... and generic Active Pharmaceutical Ingredients (APIs), today held an opening ceremony with AstraZeneca, at its Karlskoga, Sweden site to mark the commencement of a long-term ...
... "Dividends at Reckitt Benckiser, Diageo, Unilever and AB Foods look robust." Pharmaceuticals AstraZeneca and GLAXOSMITHKLINE suffered significant share price falls in 2017, although the former ...
... AstraZeneca today announced that BYDUREON BCise (exenatide extended-release) injectable suspension 2mg is now ...
... Global Influenza Vaccine Market 2018-2022 - Key Vendors are AstraZeneca, CSL, GlaxoSmithKline & Sanofi - Research and Markets ...
... an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone ...
... AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, ...
... are candidates for treatment with the PARP inhibitor Lynparza (olaparib), marketed by AstraZeneca and Merck, known as MSD outside of the U.S. and Canada. Â ...
... AstraZeneca and its global biologics research and development arm, MedImmune, today announced that ...
... report athttp://www.reportsnreports.com/purchase.aspx?name=1272908. Key players in the global heart failure drugs market: Amgen, AstraZeneca, Bayer, and Novartis. Other Prominent Vendors in the market are: Gilead, GlaxoSmithKline, ...
... - mix, unlock, inject. Rod Wooten, Vice President, Cardiovascular and Metabolic Diseases, AstraZeneca, said: "We're pleased that BYDUREON BCise, a new once-weekly treatment option in ...
... medicine market include Abbott Laboratories, Almac Group, Amgen, Inc., Astellas Pharma, Inc., AstraZeneca PLC, ASURAGEN, INC., bioMerieux SA, BRISTOL-MYERS SQUIBB COMPANY, CETICS Healthcare Technologies GmbH, ...
... "We will also initiate a randomized Phase 2 trial in collaboration with AstraZeneca for patients with metastatic pancreatic cancer, and we anticipate clinical data from ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), along with new collaborators AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and Pfizer Inc., today announced the formation of a major 'pre-competitive' ...
... big concern among existing staff who had joined from abroad. Drug maker AstraZeneca said that, while it was "in part reassured" by the Government's commitment ...
... AbbVie Inc., Encore Dermatology Inc., F. Hoffmann-La Roche AG, Glaxosmithkline plc., Medimmune (Astrazeneca), Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Valeant Pharmaceuticals Inc. ...
... A Medford manufacturer of diagnostic tests has teamed with pharmaceutical giant AstraZeneca to develop a test to detect a biomarker or substance that shows ...
... trend may have increased in recent years. For instance, in January 2016, AstraZeneca and Moderna Therapeutics entered into a collaboration to discover, co-develop and co-commercialize ...
... before China’s medical companies stand alongside Big Pharma giants like Pfizer and AstraZeneca. “It’s not whether they are going to,” said Jonathan Wang, senior managing ...
Want to see the full history on AstraZeneca Plc? Upgrade to RelSci Pro now!
Start My Free Trial